Actively Recruiting
Ex Vivo Tumor Visualization and Resection Margin Assessment Using Topically Applied Fluorescent Imaging Agents
Led by Erasmus Medical Center · Updated on 2024-08-28
200
Participants Needed
1
Research Sites
202 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a proof-of-principle study, that uses freshly resected human solid tumor specimens to assess the performance of topically applied fluorescent imaging agents for the detection of tumor tissue and close / tumor-positive resection margins ex vivo. Surgery will be performed in conformity with hospital protocol. The study will not interfere with the standard clinical care.
CONDITIONS
Official Title
Ex Vivo Tumor Visualization and Resection Margin Assessment Using Topically Applied Fluorescent Imaging Agents
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a biopsy-proven solid tumor, scheduled for surgery at the Erasmus Medical Center
- Signed and dated informed consent obtained before any study-related procedure is performed
You will not qualify if you...
- Surgical procedure was terminated
- No fresh tumor specimen available after surgery
- Participation in another clinical trial with perioperative fluorophore administration
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Erasmus University Medical Center
Rotterdam, South Holland, Netherlands, 3015 GD
Actively Recruiting
Research Team
S
Stijn Keereweer, Dr
CONTACT
B
Bo Zweedijk, Drs
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here